Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Barbara Schooley

Pain Medicine Nashville, TN Medical Doctor

NPI 1457685976 CMS profile 518820

4418 Harding Place, Ste 104, Nashville, TN 37205

Open in the dashboard

General payments

$5,772

214 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Barbara Schooley of Nashville, TN is reported in the CMS Open Payments database as having received $5,772 across 214 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $406 23
2024 General $812 31
2023 General $353 8
2022 General $1,135 45
2021 General $1,956 68
2020 General $684 27
2019 General $427 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Barbara Schooley
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Barbara Schooley were reported at $406. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Barbara Schooley Pain Medicine median Middle half National median
2019 $427 $498 $126–$1,682 $163
2020 $684 $284 $80–$910 $114
2021 $1,956 $399 $112–$1,219 $132
2022 $1,135 $455 $137–$1,484 $149
2023 $353 $484 $128–$1,495 $160
2024 $812 $498 $131–$1,540 $164
2025 $406 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $3,816 153 payments
  2. Boston Scientific Corporation $1,501 43 payments
  3. Teleflex LLC $209 9 payments
  4. Atricure, Inc. $112 1 payment
  5. Curonix LLC $84 5 payments
  6. Medtronic, Inc. $51 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,772 214 payments
Products named General payments · program years 2019–2025
  1. Proclaim IPG $1,057 42 payments
  2. PROCLAIM $1,031 35 payments
  3. Proclaim Family of SCS IPGs $579 23 payments
  4. SPECTRA WAVEWRITER Pain Management $522 13 payments
  5. WaveWriter Alpha Prime 16 $321 10 payments
  6. ETERNA Neuromodulation $284 14 payments
  7. SPECTRA WAVEWRITER Pain Management $202 5 payments
  8. GENERAL PAIN MANAGEMENT $177 4 payments
  9. Axium INS DRG IPG $175 3 payments
  10. ETERNA Structural Heart $153 8 payments
  11. Other $1,240 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$4,691

Of which drugs: $5

Medicare patients

38

Average age 72

Services billed

79

20 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Diabetes 39%
Chronic kidney disease 37%
Ischemic heart disease 34%
Depression 32%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

214 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record